Results 71 to 80 of about 9,929 (176)
Managing resistant hypertension: focus on mineralocorticoid-receptor antagonists
Vascular Health and Risk Management, 2017 Juan Carlos Yugar-Toledo,1 Rodrigo Modolo,2 Ana Paula de Faria,2 Heitor Moreno2 1São José do Rio Preto Medicine School – FAMERP, São José do Rio Preto, 2School of Medical Sciences, University of Campinas (UNICAMP ...
Yugar-Toledo JC +3 more
doaj
Journal of the ASEAN Federation of Endocrine Societies, 2018 Aldosterone-producing adrenocortical carcinoma comprises less than 7% of all functioning adrenocortical carcinomas. We report a rare case of adrenocortical carcinoma with a clinical picture of primary aldosteronism and subclinical Cushing’s syndrome and ...
Karen Lazaro, Perie Adorable-Wagan
doaj
Editorial: Molecular Mechanisms in Cancer Endocrinology With Clinical Implications
Frontiers in Endocrinology, 2022 Naris Nilubol
doaj +1 more source
The Journal of the American Osteopathic Association, 1983 P L, Trinkle, M, Clearfield
openaire +2 more sources
Resistant hypertension, hyperaldosteronism, and the emerging understanding of hypercortisolism. [PDF]
Curr Opin CardiolEinhorn D, Mende C, Auchus RJ.
europepmc +1 more source
Day-case robotic adrenalectomy under ERAS protocol: early outcomes from a single-centre experience. [PDF]
World J UrolCosta Silva A +5 more
europepmc +1 more source
Optimizing the diagnosis of primary aldosteronism: The role of adrenal vein sampling and the need for high-expertise reference centers. [PDF]
J NeuroendocrinolHerrera-Martínez AD +15 more
europepmc +1 more source